[1]
I. Araujo-Filho e A. C. . Meneses do Rêgo, “Neoadjuvant Immunotherapy as a risk factor for Hashimoto’s Disease”, J Surg Cl Res, vol. 15, nº 2, p. 187–199, dez. 2024.